Heterophile

20/20 BioResponse Confirms Accuracy of Rapid Coronavirus Test Kits in Hospitals in Several U.S. States

Retrieved on: 
Friday, April 3, 2020
Biotechnology, General Health, Health, Medical specialties, Branches of biology, Medicine, Glycoproteins, Immunologic tests, Antibodies, Immunology, Immunoassay, Severe acute respiratory syndrome-related coronavirus, Immunoglobulin M, Heterophile

20/20 BioResponse, a business unit of 20/20 GeneSystems, Inc. announced today that it will begin shipping its CoronaCheck COVID-19 Rapid Antibody Test Kit.

Key Points: 
  • 20/20 BioResponse, a business unit of 20/20 GeneSystems, Inc. announced today that it will begin shipping its CoronaCheck COVID-19 Rapid Antibody Test Kit.
  • One of the evaluators, Dr. Charles H. Miranda, MD, from South Denver Internal Medicine, reported the product to be highly reliable.
  • The test kits are rapid immunoassays (configured like a home pregnancy test) to detect IgM and IgG antibodies to SARS-CoV-2 in blood.
  • The subject test, made in China and approved by the Chinese FDA, was previously evaluated in using 188 clinical samples.